• Pharmacology
  • Allergy, Immunology, and ENT
  • Cardiology
  • Emergency Medicine
  • Endocrinology
  • Adolescent Medicine
  • Gastroenterology
  • Infectious Diseases
  • Neurology
  • OB/GYN
  • Practice Improvement
  • Gynecology
  • Respiratory
  • Dermatology
  • Mental, Behavioral and Development Health
  • Oncology
  • Rheumatology
  • Sexual Health
  • Pain

Committee focuses on healthcare disparities

Article

On June 4, the Health Information Technology Policy Committee's meaningful use workgroup gave testimony on how to include in the definition of "meaningful use" measures that could reduce racial, ethnic or any other disparities in the health of patients.

On June 4, the Health Information Technology (HIT) Policy Committee's meaningful use workgroup gave testimony on how to include in the definition of "meaningful use" measures that could reduce racial, ethnic, or any other disparities in the health of patients.

To be eligible to receive payments under the American Recovery and Reinvestment Act of 2009 (ARRA) incentive programs, healthcare providers must be able to demonstrate meaningful use of their certified electronic health record (EHR) system. The first stage of the proposed meaningful use requirements will have providers collect data on their patients' race, ethnicity, and language and generate reports covering these areas by 2011.

Speakers suggested that reducing healthcare disparities could be included in the quality measures that providers report in order to qualify for meaningful use incentive payments.

Related Videos
Venous thromboembolism, Heparin-induced thrombocytopenia, and direct oral anticoagulants | Image credit: Contemporary Pediatrics
Jessica Peck, DNP, APRN, CPNP-PC, CNE, CNL, FAANP, FAAN
Sally Humphrey, DNP, APRN, CPNP-PC | Image Credit: Contemporary Pediatrics
Ashley Gyura, DNP, CPNP-PC | Image Credit: Children's Minnesota
Congenital heart disease and associated genetic red flags
Traci Gonzales, MSN, APRN, CPNP-PC
Donna Hallas, PhD, CPNP, PPCNP-BC, PMHS, FAANP, FAAN
Scott Ceresnak, MD
© 2024 MJH Life Sciences

All rights reserved.